// App-Quantinova.ai

M4220 2016 AHA : Death Despite Enalapril Therapy vs. Survival Despite Placebo in the Studies of Left Ventricular Dysfunction (SOLVD) Trial: Insights into the Role of Traditional Risk Factors for Mortality in Heart Failure and Reduced Ejection Fraction (HFrEF)

Researchers

Presenter

  • Daniel J Dooley

Principal Investigators

  • Apostolis Tsimploulis

  • Richard M Allman

  • Wilbert Aronow

  • George Howard

  • Gregg C Fonarow

  • Ali Ahmed

  • Cherinne Arundel

  • Ross Fletcher

  • Javed Butler

  • Prakash Deedwania

  • Michel White

  • Ioannis Kanonidis

  • Charity Morgan

  • Wen-Chih Wu

Medical Centers

  • University of Alabama at Birmingham, Birmingham, AL

  • New York Medical College, Valhalla, NY

  • Montreal Heart Institute, Montreal, Quebec, Canada

  • Georgetown Univ/MedStar Washington Hosp Ctr, Washington, DC

  • UCSF Fresno, Fresno, CA

  • Washington DC Veterans Affairs Medical Center, Washington, DC

  • Aristotle University of Thessaloniki, Thessaloniki, Greece

  • Stony Brook University, Stony Brook, NY

  • UCLA, Los Angeles, CA

  • Providence Veterans Affairs Medical Ctr, Providence, RI

  • Washington DC Veterans Affairs Medical Center, Washington, DC

Locations

  • United States

  • Canada

  • Greece

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

Disease

  • Heart failure with reduced ejection fraction

  • Left ventricular dysfunction

  • Congestive heart failure

Biomarkers

  • N/A

Drug/Treatment

  • Enalapril maleate

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved